Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, July 13, 2023
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
Matthew Sykes Maintained (TWST) at Hold with Increased Target to $20 on, Jul 13th, 2023
Matthew Sykes of Goldman Sachs, Maintained "Twist Bioscience Corporation" (TWST) at Hold with Increased Target from $18 to $20 on, Jul 13th, 2023.
Matthew has made no other calls on TWST in the last 4 months.
There are 2 other peers that have a rating on TWST. Out of the 2 peers that are also analyzing TWST, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Matthew
- Catherine Ramsey of "Baird" Maintained at Buy with Decreased Target to $18 on, Monday, May 8th, 2023
- Luke Sergott of "Barclays" Maintained at Buy with Decreased Target to $20 on, Monday, May 8th, 2023
